Cipla, Strides Pharma, and Glenmark Recall Products in the US

HEALTHCARE

Drug producers Strides Pharma, Glenmark, and Cipla are recalling products in the United States, which is the largest market for medicines in the world, because of manufacturing issues. According to report, the US Food and Drug Administration (FDA), Glenmark Pharmaceuticals Inc. is recalling more than 72,000 units of blood pressure lowering drugs because of packaging issues.

In a separate report, Strides Pharma Science is recalling 1,032 bottles of Prednisone tablets, a medication used to treat several conditions, including allergic reactions, asthma, inflammatory bowel diseases, and arthritis, among others.

US FDA said, Cipla USA, Inc., based in New Jersey, the US, is recalling 7,992 bottles of Difluprednate Ophthalmic Emulsion, which is used to treat pain and swelling after eye surgery in the United States Market. The US FDA added that, there were complaints regarding defective container closures, and the affected lot was produced in India, and marketed in the United States by Cipla USA Inc.

See also  UK Records Over 10,000 Covid-19 Cases for First Time in 4 Months

According to the FDA, the United States is by far the biggest market for pharmaceutical products in the world. In the last financial year, the pharmaceutical exports of India stood at around 24.62 billion dollars, with the United Kingdom, the United States, Russia, South Africa, and Nigeria emerging as the top five destinations in the world.